Detalhe da pesquisa
1.
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Int J Infect Dis
; 126: 164-173, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403819
2.
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine
; 40(13): 2068-2075, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35164986
3.
Incremento de los costos del Programa Nacional de Inmunización por la introducción del candidato vacunal contra neumococo / Increase in the costs of the National Immunization Program due to the introduction of the pneumococcal vaccine candidate
Rev. cuba. salud pública
; 48(2): e3203, abr.-jun. 2022. tab
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1409292
4.
Evaluación del Programa de Control Sanitario Internacional en el Policlínico "Nguyen Van Troi" de Centro Habana, La Habana, 2007 / Evaluation of the International Health Control in the "Nguyen Van Troi" polyclinic of Centro Habana municipality, La Habana, 2007
Rev. cuba. hig. epidemiol
; 49(2): 231-237, Mayo-ago. 2011.
Artigo
em Espanhol
| LILACS | ID: lil-615303
5.
Calidad de prescripción de antimicrobianos en servicios seleccionados en hospitales clínico quirúrgicos / Quality of antimicrobials prescription in selected services in clinical surgical hospitals
Arch. venez. farmacol. ter
; 28(2): 63-65, jul. 2009. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-630361